The HTR2A rs6311 and rs6313 polymorphisms and atypical antipsychotics response in schizophrenia: a scoping review

Nurul Hidayah, Muthi Ikawati, Mustafa Mahmud Amin, Zullies Ikawati

Open source

DOI
10.1097/fpc.0000000000000600
Published
2026-07-28
Container
Pharmacogenetics and Genomics
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/fpc.0000000000000600,
  title = {The HTR2A rs6311 and rs6313 polymorphisms and atypical antipsychotics response in schizophrenia: a scoping review},
  author = {Nurul Hidayah and Muthi Ikawati and Mustafa Mahmud Amin and Zullies Ikawati},
  year = {2026},
  journal = {Pharmacogenetics and Genomics},
  doi = {10.1097/fpc.0000000000000600},
  url = {https://doi.org/10.1097/fpc.0000000000000600}
}

RIS

TY  - JOUR
TI  - The HTR2A rs6311 and rs6313 polymorphisms and atypical antipsychotics response in schizophrenia: a scoping review
AU  - Nurul Hidayah
AU  - Muthi Ikawati
AU  - Mustafa Mahmud Amin
AU  - Zullies Ikawati
PY  - 2026
JO  - Pharmacogenetics and Genomics
DO  - 10.1097/fpc.0000000000000600
UR  - https://doi.org/10.1097/fpc.0000000000000600
ER  - 

APA

Hidayah, N., Ikawati, M., Amin, M. M., & Ikawati, Z. (2026). The HTR2A rs6311 and rs6313 polymorphisms and atypical antipsychotics response in schizophrenia: a scoping review. Pharmacogenetics and Genomics. https://doi.org/10.1097/fpc.0000000000000600

Source records